FIXX - Homology Medicines Inc. Looks to Continue to Trade Below its Annual-Low Share Price Today
Shares of Homology Medicines Inc. (NASDAQ:FIXX) traded today at $6.35, breaking its 52-week low. This new low was reached on approximately average trading volume as 857,000 shares traded hands, while the average 30-day volume is approximately 820,000 shares.
Homology Medicines Inc. (NASDAQ:FIXX) has potential upside of 5.3% based on a current price of $6.36 and analysts' consensus price target of $6.70.
In the past 52 weeks, Homology Medicines Inc. share prices are bracketed by a current low of $6.35 and a high of $17.34 and is now at $6.36.
Homology Medicines Inc is a US-based genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases with significant unmet medical needs by curing the underlying cause of the disease. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nuclease-free gene editing modality across a range of genetic disorders.
Receive IBN Spotlights - "Bite Size" Small, Mid and Large-Cap Technical Indicator Alerts
To stay connected with our complimentary IBN Spotlights, please visit https://IBN.fm/connected
About InvestorBrandNetwork (IBN)
InvestorBrandNetwork (IBN) consists of 50+ trusted financial brands introduced to the investment public over the course of 15+ years. Through these brands, IBN provides (1) access to our Investor Press Release Wire Solutions via InvestorWire (IW) to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions via IW to ensure maximum impact; (4) full-scale distribution to an enormous social media audience that includes millions of followers; and (5) a full array of corporate communications solutions focused on the IBN Podcast Series. With a proven track record serving 500+ client partners, IBN is the key to a more effective market communication campaign.
For more information, please visit https://www.InvestorBrandNetwork.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer